Clinical Trial

Annoveraâ„¢ Drug-Drug Interaction Study

Study Description

Annoveraâ„¢ Drug-Drug Interaction Study

A Drug-Drug Interaction (DDI) study to evaluate the effects of itraconazole and rifampin on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol from the Annovera Contraceptive Vaginal System (CVS)

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Segesterone Acetate and Ethinyl Estradiol

Contraceptive Vaginal System

Drug - Rifampin

CYP3A inducer

Drug - Itraconazole

CYP3A inhibitor

Additional Information

Official Study Title

A Drug-Drug Interaction Study to Evaluate the Effects of Strong CYP3A Induction and Inhibition on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol From the Annoveraâ„¢ Contraceptive Vaginal System

Clinical Trial ID

NCT04290390

ParticipAid ID

egJvZd